Please login to the form below

Not currently logged in
Email:
Password:

Growing Axon makes raft of new hires

The UK comms agency welcomes seven new starters across its med comms, PR and finance teams

Axon

London, UK-based communications agency Axon has made seven new appointments across its med comms, PR and finance teams.

Joining the agency’s medical communications team are Saroshi Amirthalingam, who moves from Kent, UK-based Elements Communications where she was medical writer and takes up the same role in Axon, and Vincent Foster - who also  joins as medical writer.

Kate Picard joins the team as its publications project manager - moving from The British Editorial Society of Bone and Joint Surgery where she served as editorial production manager - alongside Amy Fernandes who takes up a role at Axon as a senior programme executive.

In the agency's PR team Sash Rosenberg joins from Hill and Knowlton Strategies as a programme executive and Axon's finance team has appointed Daniel Wickings and Scott Hammond as senior accounts assistants.

Mirana Dini, managing partner of AXON London, said: “We’re having a fantastic run of it right now, and the addition of these new colleagues is a testament to our continued growth and dedication we have to finding and hiring the best people for our business.”

14th June 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...

Infographics